Back

Disruption of IL-17 signaling in the respiratory mucosa results in invasive streptococcal infection

Pandey, M.; Mills, J.-L.; Lepletier, A.; Ozberk, V.; Dooley, J.; Kaden, J.; Calcutt, A.; Huo, Y.; Hicks, A.; Zaid, A.; Good, M.

2023-11-14 immunology
10.1101/2023.11.10.566548 bioRxiv
Show abstract

Streptococcus pyogenes infection of the upper respiratory tract and skin can lead to severe invasive streptococcal disease (ISD). Previous studies have demonstrated that the deficiency of IL-17 in mice (IL-17-/-) reduces mucosal immunity against S. pyogenes. However, the impact of IL-17 deficiency on the development of ISD is unknown. Here, we model single or repeated non-lethal, intranasal (IN) S. pyogenes M1 strain infections in immunocompetent and IL-17-/-mice to assess bacterial dissemination following a final IN or skin challenge. Immunocompetent mice that received a single S. pyogenes IN infection displayed long-lasting mucosal immunity and no systemic infection. However, in the absence of IL-17, a single IN infection resulted in the dissemination of S. pyogenes to the spleens, which was further exacerbated by repeated IN infections. Interestingly, immunity following skin challenge did not show a correlation with IL-17 and was instead associated with the activation of germinal center responses and the accumulation of neutrophils in the spleen. Our results highlight the critical role of IL-17 in preventing ISD following S. pyogenes infection of the respiratory mucosa.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.